Ihuman Financials

IH Stock  USD 1.52  0.03  1.94%   
Based on the analysis of Ihuman's profitability, liquidity, and operating efficiency, Ihuman Inc is doing better financially today then in previous quarter. It has a moderate chance of reporting better financial numbers in December. As of now, Ihuman's Accounts Payable is increasing as compared to previous years. The Ihuman's current Inventory is estimated to increase to about 17.4 M, while Total Assets are projected to decrease to under 945.7 M. Key indicators impacting Ihuman's financial strength include:
Current ValueLast YearChange From Last Year 10 Year Trend
Current Ratio1.482.8169
Way Down
Slightly volatile
The financial analysis of Ihuman is a critical element in measuring its lifeblood. Investors should not minimize Ihuman's ability to pay suppliers or employees on time, ensuring interest payments are not accumulating.

Cash And Equivalents

633.17 Million

  
Understanding current and past Ihuman Financials, including the trends in assets, liabilities, equity and income are directly related to making proper and timely investing decisions. All of Ihuman's financial statements are interrelated, with each one affecting the others. For example, an increase in Ihuman's assets may result in an increase in income on the income statement.

Ihuman Stock Summary

Ihuman competes with Boqii Holding, Lixiang Education, Huize Holding, and Kuke Music. iHuman Inc. provides intellectual development products to individual users, kindergartens, and distributors in the Peoples Republic of China. The company was founded in 1996 and is based in Beijing, the Peoples Republic of China. Ihuman Inc operates under Education Training Services classification in the United States and is traded on New York Stock Exchange. It employs 1119 people.
Specialization
Consumer Discretionary, Education & Training Services
InstrumentUSA Stock View All
ExchangeNew York Stock Exchange
ISINUS45175B1098
CUSIP45175B109
LocationChina
Business AddressBuilding B, Beijing,
SectorHotels, Restaurants & Leisure
IndustryConsumer Discretionary
BenchmarkDow Jones Industrial
Websitewww.ihuman.com
Phone86 10 5780 6606
CurrencyUSD - US Dollar

Ihuman Key Financial Ratios

Ihuman Key Balance Sheet Accounts

201920202021202220232024 (projected)
Total Assets168.3M1.0B1.1B1.3B1.5B945.7M
Other Current Liab880K90.1M104.7M118.8M438.0M459.9M
Net Debt(104.9M)(855.1M)(821.1M)(1.0B)(1.2B)(1.1B)
Retained Earnings(348.5M)(386.0M)(423.0M)(321.2M)(140.5M)(147.5M)
Accounts Payable10.3M21.6M30.5M24.2M22.1M22.3M
Cash104.9M861.7M855.4M1.0B1.2B750.2M
Other Assets2.7M784K7.8M6.4M7.4M4.0M
Net Receivables21.0M78.3M59.0M81.9M62.6M58.0M
Capital Surpluse213.1M1.1B1.1B1.1B1.2B751.9M
Inventory20.7M16.9M28.1M19.1M16.5M17.4M
Other Current Assets574K64.6M72.9M102.8M89.5M60.9M
Total Liab182.8M404.3M492.5M563.9M492.7M414.1M
Net Invested Capital(14.4M)642.7M608.4M769.5M957.8M531.7M
Total Current Assets163.1M1.0B1.0B1.3B1.4B897.1M
Cash And Equivalents104.9M861.7M855.4M1.0B1.2B633.2M
Net Working Capital(19.7M)622.2M532.3M692.7M891.7M486.6M
Short Term Debt99.8M1.5M24.7M6.1M1.9M1.8M
Intangible Assets103K11.8M27.3M24.9M23.2M16.0M

Ihuman Key Income Statement Accounts

201920202021202220232024 (projected)
Tax Provision1.4M466K(145K)23.0M33.1M34.8M
Interest Expense4.6M10.3M23.5M21.2M24.4M13.1M
Total Revenue218.7M531.9M944.7M985.5M1.0B702.3M
Gross Profit134.5M365.4M660.6M691.2M721.3M483.8M
Operating Income(278.8M)(44.5M)(54.2M)111.6M159.9M167.9M
Ebit(278.8M)(44.5M)(54.2M)111.6M159.9M167.9M
Research Development170.2M199.5M415.3M313.5M257.5M258.2M
Ebitda(278.2M)(41.6M)(47.8M)122.4M171.6M180.2M
Cost Of Revenue84.2M166.5M284.1M294.3M296.9M218.5M
Income Before Tax(274.2M)(37.0M)(37.2M)132.8M202.6M212.7M
Net Income(275.6M)(37.5M)(37.1M)109.8M180.9M190.0M
Income Tax Expense1.4M466K(145K)23.0M21.7M22.7M

Ihuman Key Cash Accounts

201920202021202220232024 (projected)
Change To Inventory8.9M2.2M(12.6M)6.7M3.0M1.7M
Investments(2.4M)(15.9M)(32.0M)(32.8M)(6.5M)(6.8M)
Change In Cash98.8M756.8M(6.3M)194.6M163.8M222.4M
Free Cash Flow40.2M207.1M5.9M181.9M165.6M109.2M
Depreciation597K2.8M6.4M10.8M11.7M6.0M
Other Non Cash Items249K11.3M21.8M28.8M(52.1M)(49.5M)
Capital Expenditures2.4M15.9M32.3M6.6M6.5M11.8M
Net Income(275.6M)(37.5M)(37.1M)109.8M180.9M190.0M
End Period Cash Flow104.9M861.7M855.4M1.0B1.2B750.2M
Change To Netincome270.8M92.6M38.6M41.8M37.7M71.0M

Ihuman Financial Ratios Relationships

Comparative valuation techniques use various fundamental indicators to help in determining Ihuman's current stock value. Our valuation model uses many indicators to compare Ihuman value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Ihuman competition to find correlations between indicators driving Ihuman's intrinsic value. More Info.
Ihuman Inc is currently regarded as number one stock in return on equity category among its peers. It also is currently regarded as number one stock in return on asset category among its peers reporting about  0.31  of Return On Asset per Return On Equity. The ratio of Return On Equity to Return On Asset for Ihuman Inc is roughly  3.24 . As of now, Ihuman's Return On Equity is increasing as compared to previous years. The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Ihuman's earnings, one of the primary drivers of an investment's value.

Ihuman Inc Systematic Risk

Ihuman's systematic risk plays a vital role in portfolio allocation when considering its stock to be added to a well-diversified portfolio. Ihuman volatility which cannot be eliminated through diversification, requires returns over the risk-free rate. Over the long run, a well-diversified portfolio provides returns that match its exposure to systematic risk. In this case, investors face a trade-off between expected returns and systematic risk and, therefore, can only reduce a portfolio's exposure to systematic risk by sacrificing expected returns on the portfolio.
The output start index for this execution was three with a total number of output elements of fifty-eight. The Beta measures systematic risk based on how returns on Ihuman Inc correlated with the market. If Beta is less than 0 Ihuman generally moves in the opposite direction as compared to the market. If Ihuman Beta is about zero movement of price series is uncorrelated with the movement of the benchmark. if Beta is between zero and one Ihuman Inc is generally moves in the same direction as, but less than the movement of the market. For Beta = 1 movement of Ihuman is generally in the same direction as the market. If Beta > 1 Ihuman moves generally in the same direction as, but more than the movement of the benchmark.

Ihuman Thematic Clasifications

Ihuman Inc is part of several thematic ideas from Railroads to Books. If you are a theme-oriented, socially responsible, and at the same time, a result-driven investor, you can align your investing habits with your values without jeopardizing your expectations about returns. You can easily create an optimal portfolio of stocks, ETFs, funds, or cryptocurrencies based on a specific theme of your liking. Get More Thematic Ideas
Today, most investors in Ihuman Stock are looking for potential investment opportunities by analyzing not only static indicators but also various Ihuman's growth ratios. Consistent increases or decreases in fundamental ratios usually indicate a possible pattern that can be successfully translated into profits. However, when comparing two companies, knowing each company's growth growth rates may not be enough to decide which company is a better investment. That's why investors frequently use static breakdown of Ihuman growth as a starting point in their analysis.

Price Earnings To Growth Ratio

0.11

As of now, Ihuman's Price Earnings To Growth Ratio is increasing as compared to previous years.

Ihuman November 24, 2024 Opportunity Range

Along with financial statement analysis, the daily predictive indicators of Ihuman help investors to analyze its daily demand and supply, volume, patterns, and price swings to determine the real value of Ihuman Inc. We use our internally-developed statistical techniques to arrive at the intrinsic value of Ihuman Inc based on widely used predictive technical indicators. In general, we focus on analyzing Ihuman Stock price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build Ihuman's daily price indicators and compare them against related drivers.

Complementary Tools for Ihuman Stock analysis

When running Ihuman's price analysis, check to measure Ihuman's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Ihuman is operating at the current time. Most of Ihuman's value examination focuses on studying past and present price action to predict the probability of Ihuman's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Ihuman's price. Additionally, you may evaluate how the addition of Ihuman to your portfolios can decrease your overall portfolio volatility.
USA ETFs
Find actively traded Exchange Traded Funds (ETF) in USA
Stocks Directory
Find actively traded stocks across global markets
Companies Directory
Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals
Odds Of Bankruptcy
Get analysis of equity chance of financial distress in the next 2 years
Bollinger Bands
Use Bollinger Bands indicator to analyze target price for a given investing horizon
Balance Of Power
Check stock momentum by analyzing Balance Of Power indicator and other technical ratios
Portfolio Center
All portfolio management and optimization tools to improve performance of your portfolios
Bond Analysis
Evaluate and analyze corporate bonds as a potential investment for your portfolios.
Portfolio Rebalancing
Analyze risk-adjusted returns against different time horizons to find asset-allocation targets